13F filer · CIK 1274403
ARCH Venture Management, LLC
CHICAGO, IL · filing since Q4 2018 · last filing Aug 14, 2026
Reported value
$1.1B
+$423.2M vs prior
Positions
12
New / sold out
3 / 1
Added / reduced
0 / 1
Turnover
0.5%
buys $318.9M · sells $4.3M
Top-10 weight
99.3%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | PARABILIS MEDICINES INC | +6,412,780 | – | +$175.5M |
| New | SEAPORT THERAPEUTICS INC | +6,294,951 | – | +$136.6M |
| New | BOUNDLESS BIO INC | +2,694,095 | – | +$6.7M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | VIR BIOTECHNOLOGY INC | -222,500 | -1.7% | $-2.3M |
| Sold out | Q32 BIO INC | -320,482 | -100.0% | $-2.1M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PARABILIS MEDICINES INCCOM | 6,412,780 | $175.5M | 15.95% |
| 2 | BEAM THERAPEUTICS INCCOM | 4,540,132 | $155.8M | 14.16% |
| 3 | RAPPORT THERAPEUTICS INCCOM | 3,728,738 | $155.4M | 14.12% |
| 4 | SEAPORT THERAPEUTICS INCCOMMON STOCK | 6,294,951 | $136.6M | 12.42% |
| 5 | ERASCA INCCOM | 7,091,557 | $129.9M | 11.81% |
| 6 | VIR BIOTECHNOLOGY INCCOM | 12,694,163 | $129.4M | 11.76% |
| 7 | MAZE THERAPEUTICS INCCOM | 4,120,053 | $123.0M | 11.18% |
| 8 | LYELL IMMUNOPHARMA INCCOM NEW | 3,247,162 | $45.5M | 4.14% |
| 9 | GENERATE BIOMEDICINES INCCOM SHS | 1,944,426 | $32.8M | 2.98% |
| 10 | 10X GENOMICS INCCL A COM | 217,834 | $8.4M | 0.76% |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.